tiprankstipranks
Advertisement
Advertisement

DE:78Q Stock Latest News

Philogen Publishes 2025 Financial and Governance Reports Ahead of April 2026 Shareholders’ Meeting
Company AnnouncementsPhilogen Publishes 2025 Financial and Governance Reports Ahead of April 2026 Shareholders’ Meeting
2d ago
Philogen Discloses March Share Purchases by Mediobanca on Italian Market
PremiumCompany Announcements
Philogen Discloses March Share Purchases by Mediobanca on Italian Market
2d ago
Philogen Publishes Documentation Ahead of April 2026 Shareholders’ Meeting
PremiumCompany Announcements
Philogen Publishes Documentation Ahead of April 2026 Shareholders’ Meeting
11d ago
Philogen posts record 2025 profit on RayzeBio deal, plans dividend and R&D push
PremiumCompany Announcements
Philogen posts record 2025 profit on RayzeBio deal, plans dividend and R&D push
14d ago
Philogen Expands Treasury Share Buyback, Nears 0.87% of Share Capital Held
PremiumCompany Announcements
Philogen Expands Treasury Share Buyback, Nears 0.87% of Share Capital Held
1M ago
Philogen Adds to Treasury Stock with Ongoing Share Buyback on Euronext Milan
PremiumCompany AnnouncementsPhilogen Adds to Treasury Stock with Ongoing Share Buyback on Euronext Milan
1M ago
Philogen Advances New Skin Cancer Trial, Extending Long‑Term Upside Optionality for DE:78Q Investors
Premium
Company Announcements
Philogen Advances New Skin Cancer Trial, Extending Long‑Term Upside Optionality for DE:78Q Investors
2M ago
78Q
Philogen Expands Treasury Stock as Biotech Buyback Program Advances
Premium
Company Announcements
Philogen Expands Treasury Stock as Biotech Buyback Program Advances
2M ago
Spouse of Philogen Chairman Sells 800 Shares in Insider Transaction Disclosure
PremiumCompany Announcements
Spouse of Philogen Chairman Sells 800 Shares in Insider Transaction Disclosure
2M ago
Philogen Increases Treasury Stock with New Tranche of Share Buybacks
PremiumCompany Announcements
Philogen Increases Treasury Stock with New Tranche of Share Buybacks
2M ago
Philogen Advances Early RA Trial With F8IL10, Signaling Continued Pipeline Progress
PremiumCompany Announcements
Philogen Advances Early RA Trial With F8IL10, Signaling Continued Pipeline Progress
3M ago
78Q
Philogen Completes Early Trial of New Prostate Cancer Imaging Agent: What Investors Should Watch
PremiumCompany Announcements
Philogen Completes Early Trial of New Prostate Cancer Imaging Agent: What Investors Should Watch
3M ago
78Q
Philogen’s New Phase 2 Study: A Potential Game-Changer in Skin Cancer Treatment
PremiumCompany AnnouncementsPhilogen’s New Phase 2 Study: A Potential Game-Changer in Skin Cancer Treatment
4M ago
78Q
Philogen’s New Phase 2 Study: A Potential Game-Changer in Basal Cell Carcinoma Treatment
Premium
Company Announcements
Philogen’s New Phase 2 Study: A Potential Game-Changer in Basal Cell Carcinoma Treatment
4M ago
78Q
Philogen Updates on Share Buyback Program
Premium
Company Announcements
Philogen Updates on Share Buyback Program
4M ago
Philogen S.p.A. Reports Strong Financial Position and Advances in Clinical Trials
PremiumCompany Announcements
Philogen S.p.A. Reports Strong Financial Position and Advances in Clinical Trials
5M ago
Philogen S.p.A. Updates Share Buyback Program
PremiumCompany Announcements
Philogen S.p.A. Updates Share Buyback Program
6M ago
Philogen S.p.A. Updates on Share Buyback Program
PremiumCompany Announcements
Philogen S.p.A. Updates on Share Buyback Program
6M ago
Philogen Updates on Share Buyback Program
PremiumCompany Announcements
Philogen Updates on Share Buyback Program
6M ago
Philogen Reports Strong Revenue Growth and Advances in Clinical Pipeline
PremiumCompany AnnouncementsPhilogen Reports Strong Revenue Growth and Advances in Clinical Pipeline
7M ago
Philogen S.p.A. Updates on Share Buyback Program
Premium
Company Announcements
Philogen S.p.A. Updates on Share Buyback Program
7M ago
Philogen Finalizes $1.35 Billion OncoACP3 License Agreement with RayzeBio
Premium
Company Announcements
Philogen Finalizes $1.35 Billion OncoACP3 License Agreement with RayzeBio
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >